Iliamna1

Antiv***l Drug for C***D

Taylor Penley August 5, 2021 at 11:23am

Since the dawn of the p******c, we’ve searched for ways to treat C****-** — putting forth the antimalarial drug hydroxychloroquine and the antiparasitic agent ivermectin as potential treatment agents, but all of that lost its luster when v*****es arrived.
One Israeli professor, however, is reviving the plausibility of previous ivermectin studies in research that has yet to be peer-reviewed.
The double-blinded trial study out of the Sheba Medical Center in Tel Hashomer shows promising results in reducing “v***l shedding among nonhospitalized patients with mild to moderate C****-**,” according to The Jerusalem Post.
Professor Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba, conducted the trial between May 2020 and January 2021, using 89 adult volunteers who were diagnosed with C****-** and contained in state-run C***D hotels, according to the outlet.
Schwartz administered the drug to 50 percent of the participants and administered a placebo to those remaining an hour before a meal for three consecutive days.
Schwartz swabbed participants with standard nasopharyngeal swab PCR tests to examine their v***l load every two days and found that, by the sixth day, nearly 72 percent of those who consumed the drug tested negative for the v***s while only 50 percent tested negative in the placebo group.
The Jerusalem Post report mentioned another promising discovery — only 13 percent of the ivermectin group were still infectious at the end of the six days.
And the placebo group? Fifty percent — nearly four times as many — were still infectious, according to the outlet.
Now the potentially groundbreaking study aims for the scientific community’s approval of ivermectin as an effective C***D treatment.
If authorized, not only would this help combat C***D cases in those without immunity, but it could also help those experiencing breakthrough infections following v******tion.
“Our study shows first and foremost that ivermectin has antiv***l activity,” Schwartz said, according to the Jerusalem Post.
“It also shows that there is almost a 100% chance that a person will be noninfectious in four to six days, which could lead to shortening isolation time for these people. This could have a huge economic and social impact.”
Not to mention, ivermectin offers an affordable solution to a long-standing dilemma. In fact, it’s estimated to cost less than $1 a day.
If it’s approved, it would seem like an unlikely hero, right?
The drug was first approved by the FDA in 1987 for antiparasitic purposes and, according to the National Institutes of Health, has since been used to treat a number of tropical diseases, including “onchocerciasis, helminthiases, and scabies.”
It’s also been documented to effectively treat head lice in infected patients.
But research shows the drug’s abilities might not end there.
Ivermectin is also under evaluation for potential reduction in malaria t***smission, and according to the Jerusalem Post, a number of studies have shown its promising antiv***l ability against ailments including HIV, influenza, Zika and the West Nile V***s.
Though the NIH clarifies that the drug is “not approved by the FDA for the treatment of any v***l infection,” it may still show promise with v***ses like C****-** and could obtain approval in the future.
At this point, it’s up to the scientific community to determine whether the evidence favors ivermectin as a potential C***D treatment.
It’s nice to see science at least entertaining the notion now, considering many have so vehemently opposed the idea of an already-existent C***D treatment in the past.
The FDA still maintains that C***D-infected patients should not take ivermectin as a treatment or a preventative, of course, but it’s certainly possible that will change in light of more research.

lpnmajor Loc: Arkansas

Pseudo science.

RandyBrian Loc: Texas

Says the guy who can't back up his opinions, and bails when confronted with facts.

Liberty Tree

That's him!

peg w

I will belive in ivermectin when I see a couple of peer reviewed articles on it's effectiveness. As far as chloroquine, it is only effective within 48 hours of the first symptoms. After that, it is useless. Why best this old drum when there are now some drugs in use that everyone agrees on that are effective?

archie bunker Loc: Texas

How bout some real life experience with it peg?
One of my granddaughters started showing symptoms, and tested positive for it this past Saturday. She was prescribed ivermectin, and today, it's like she was never sick.
How about we have some long term "peer reviewed" studies of these "v*****es" that allow you to contract, and spread c***d?
More real life experience, and seeing with my own eyes. Where I work, we currently have 7 out with c***d, and 5 of those were "v******ted" against it. I was told that by a supervisor today.

Sonny Magoo Loc: Where pot pie is boiled in a kettle

Yes ivermectin has shown to be effective along the Mexican border. It's easy to obtain there. You know..Mexican water and parasites. Anyway, if administered within 48 hours of first symptoms along with Hydrocloroqine and Vitamin D, symptoms abate in next 48 hours.
No Pseudo...real experience.

Iliamna1

It's interesting that you would bring up Vitamin D. Some very prominent universities have done landmark studies that clearly show people deficient in Vit D3 are far more susceptible to ALL the coronov***ses and iother illnesses.. And darker skinned people tend to have less of it. This is easily treated with a Vit D3 tablet every day and should be accompanied with Vit C and Zinc which are available in any good daily vitamin tablet. Another population that has chronic deficiencies of Vit D3 are the elderly. Guess what? The main people catching C***d are the unv******ted, elderly dark skinned peolple, but for some reason, you don't hear this on MSM.

Iliamna1

Please educate me. How was the article "pseudo science?" This wa a study done at an accredited University by a rofessor of medicine, Professor Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba, who conducted the trial between May 2020 and January 2021, using 89 adult volunteers who were diagnosed with C****-** and contained in state-run C***D hotels, according to the outlet.

Dr. Schwartz administered the drug to 50 percent of the participants and administered a placebo to those remaining an hour before a meal for three consecutive days. This constitutes a DOUBLE-BLINDED STUDY which is the gold standard of medical research.

fastforwardr1

Iliamna1

This doctor nicely edited, condensensed and confirmed what I had been reading about for the last 6 months. I'm going to foreward this to a bunch of my friends. It's only about 26 minutes long, but has some life-saving information. Thank you, fastforward.